Acarbose: a review of US clinical experience

This publication has 8 references indexed in Scilit:

• Diabetes in Urban African Americans. V. Use of Discussion Groups to Identify Barriers to Dietary Therapy Among Low-Income Individuals With Non-Insulin-Dependent Diabetes Mellitus
  The Diabetes Educator, 1996
• Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial
  Kidney International, 1995
• Reduction of Glycosylated Hemoglobin and Postprandial Hyperglycemia by Acarbose in Patients With NIDDM: A placebo-controlled dose-comparison study
  Diabetes Care, 1995
• Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus
  The American Journal of Medicine, 1995
• United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years
  BMJ, 1995
• The Effect of Intensive Diabetes Treatment on the Progression of Diabetic Retinopathy in Insulin-Dependent Diabetes Mellitus
  Archives of Ophthalmology (1950), 1995
• Long-term Efficacy and Safety of Acarbose in the Treatment of Obese Subjects With Non—Insulin-Dependent Diabetes Mellitus
  Archives of internal medicine (1960), 1994
• The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1993